Published 1 month ago

Bayer to seek approval for menopausal relief drug after third trial win

Summary by Ground News

Bayer says it will request regulatory approval for its menopause drug. The daily pill was shown to ease hot flashes in a third late-stage trial. The readouts mark a slight turn of fortune for embattled Bayer. In November Bayer aborted a large late- stage trial because of a new anti-blood-clotting therapy.

0 Articles

All

Left

Center

Right

WTVB

Bayer to seek approval for menopausal relief drug after third trial win

By Ludwig Burger FRANKFURT (Reuters) -Bayer said on Tuesday that it would request regulatory approval for its menopause drug after the daily pill was shown to ease hot flashes in a third late-stage trial, providing some relief for its pharmaceuticals unit that is reeling from a recent development setback. Germany’s Bayer said in a statement that a third Phase III trial with its elinzanetant drug candidate provided supporting data on efficacy an…

1 month ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.